>> Long build up is seen in CIPLA Futures, where we have seen 4 per cent rise in the open interest on the day when Cipla ...

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by ...

Welcome to the Cipla Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...

The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after ...

Cipla's oncology drug Abraxane will be launched from its Goa facility while respiratory drug Advair will be rolled out from ...

Cipla , one of India's largest drugmaker by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by ...

Cipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the ...

Cipla's earnings before interest, tax, depreciation, and amortisation (EBITDA) jumped nearly 16% year-on-year to Rs 1,989 ...

Cipla reported a 48.73% increase in consolidated net profit for Q3 2024. The growth was attributed to improved performance ...

The reported net profit is higher with the Rs 1,225 crore average net profit estimated by 10 brokerages polled by ...

Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the ...